d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study.
Basant Pradhan, Ludmil Mitrev, Ruin Moaddell, Irving W. Wainer
Biochim Biophys Acta Proteins Proteom March 18, 2018 DOI: 10.1016/j.bbapap.2018.03.006 via PubMed Central
Summary
AI-generated from the abstractIn a pilot study, d-serine levels may serve as a biomarker for clinical response in individuals with post-traumatic stress disorder (PTSD) treated with (R,S)-ketamine infusion combined with TIMBER psychotherapy. The work suggests that changes in d-serine could reflect treatment outcomes, offering a potential biological indicator for monitoring therapeutic efficacy.
Study at a glance
| Characteristics | Pilot study Peer reviewed |
|---|---|
| Population | People with post-traumatic stress disorder (PTSD) |
| Interventions | (R S)-ketamine infusion TIMBER psychotherapy |
| Citations | 67 |
| Key finding | d-Serine may be a biomarker for clinical response in PTSD patients treated with (R,S)-ketamine infusion and TIMBER psychotherapy. |
Abstract
d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study.